List of Figures
Figure 1:Packaging of Surgical/Medical Devices
Figure 2:Criteria for the Selection of Pharmaceutical Packaging Material and Type
Figure 3:Dosage Form and Package Form of Pharmaceutical Medications
Figure 4:Dosage Form and Package Form of Pharmaceutical Medications
Figure 5:Pharmaceutical Packaging Equipment Market Segmentation Flowchart
Figure 6:Global Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2017 (USD Billion)
Figure 7:Global Pharmaceutical Packaging Equipment Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 8:Distributions of persons aged 60 years or above by region in millions, 2015 and 2030F
Figure 9:Population ages 65 and above, By Select Region, 2013-2017 (% of total)
Figure 10:rojected global population aged 60 years & above (In Billions)
Figure 11:Projected global population (In Billions)
Figure 12:World Life expectancy at birth for selected periods
Figure 13:Life expectancy at birth for selected periods, By Region
Figure 14:GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Figure 15:GDP Per Capita PPP, By Select Countries, 2022F (USD)
Figure 16:Donated funds for research and development by disease, 2016 (USD Million)
Figure 17:Obese Population, By Country, 2017 (In Millions)
Figure 18:Global Diabetic Adult Population, 2017 & 2045 (In %)
Figure 19:Healthcare Expenditure (Share of GDP), By Select Country, 2012-2016 (In %)
Figure 20:Global Pharmaceutical Packaging Equipment Market Size, By Product Type, 2017 (%)
Figure 21:Global Pharmaceutical Packaging Equipment Market Size, By Product Type, 2023 (%)
Figure 22:Global Pharmaceutical Solids Packaging Equipment Market, By Value, 2013-2017 (USD Billion)
Figure 23:Global Pharmaceutical Solids Packaging Equipment Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 24:Global Pharmaceutical Semi-Solids Packaging Equipment Market, By Value, 2013-2017 (USD Billion)
Figure 25:Global Pharmaceutical Semi-Solids Packaging Equipment Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 26:Global Pharmaceutical Liquids Packaging Equipment Market, By Value, 2013-2017 (USD Billion)
Figure 27:Global Pharmaceutical Liquids Packaging Equipment Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 28:Global Pharmaceutical Packaging Equipment Market Size, By Package Type, 2017 (%)
Figure 29:Global Pharmaceutical Packaging Equipment Market Size, By Package Type, 2023 (%)
Figure 30:Global Primary Pharmaceutical Packaging Equipment Market, By Value, 2013-2017 (USD Billion)
Figure 31:Global Primary Pharmaceutical Packaging Equipment Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 32:Global Pharmaceutical Solids Packaging Equipment Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 33:Global Pharmaceutical Solids Packaging Equipment Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 34:Global Secondary Pharmaceutical Packaging Equipment Market, By Value, 2013-2017 (USD Billion)
Figure 35:Global Secondary Pharmaceutical Packaging Equipment Market, By Value, Forecast, 2018-2023 (USD Billion)
Figure 36:Global Secondary Pharmaceutical Packaging Equipment Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 37:Global Labeling & Serialization Equipment Market, By Value, 2013-2017 (USD Billion)
Figure 38:Global Labeling & Serialization Equipment Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 39:Global Pharmaceutical Packaging Equipment Market Size, By Region, 2017 (%)
Figure 40:Global Pharmaceutical Packaging Equipment Market Size, By Region, 2023 (%)
Figure 41:North America Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2017 (USD Billion)
Figure 42:North America Pharmaceutical Packaging Equipment Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 43:North America Healthcare Cost Per Capita, 2016 (USD)
Figure 44:North America Population Ages 65 and above, 2012-2016 (% of Total)
Figure 45:North America GDP, 2012-2016 (USD Trillion)
Figure 46:North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 47:North America DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 48:North America DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 49:North America DALYs of COPD (2013-2016 %)
Figure 50:North America DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 51:North America DALYs of Diabetes (2013-2016, %)
Figure 52:Savings from Generics in U.S Healthcare System, 2012-2016 (USD Billion)
Figure 53:Savings from U.S Healthcare System, By Leading Diseases, 2016 (USD Billion)
Figure 54:North America Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 55:North America Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 56:U.S. Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 57:U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 58:U.S., Population ages 65 and above, 2013-2016 (% of total)
Figure 59:U.S., Population ages 65 and above, Forecast (In Millions)
Figure 60:United States DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 61:United States DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 62:United States DALYs of COPD (2013-2016, %)
Figure 63:United States DALYs of Alzheimer Disease and Other Dementias (2013-2016 %)
Figure 64:United States DALYs of Diabetes Mellitus (2013-2016 %)
Figure 65:U.S Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 66:U.S Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 67:Canada Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 68:Canada, Expenditure on Health as a share of GDP, 2012-2016 (in %)
Figure 69:Canada, Per Capita Healthcare Expenditure, 2012-2016 (USD)
Figure 70:Canada, Population ages 65 and above, 2012-2016 (% of total)
Figure 71:Canada DALYs of Ischemic Heart Disease (2013-2016 %)
Figure 72:Canada DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 73:Canada DALYs of COPD (2013-2016, %)
Figure 74:Canada DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 75:Canada DALYs of Diabetes (2013-2016, %)
Figure 76:Canada Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 77:Canada Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 78:Major Players in Pharmaceutical Packaging Equipment Market in North America
Figure 79:North America Pharmaceutical Packaging Equipment Market, Country Share, 2013-2017E(% of Total)
Figure 80:North America Pharmaceutical Packaging Equipment Market, Country Share, 2018F-2023F (% of Total)
Figure 81:Europe Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2017 (USD Billion)
Figure 82:Europe Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2017 (USD Billion)
Figure 83:Per Capita Health Expenditure, By Select Country, 2016 (USD)
Figure 84:European Union, Population ages 65 and above, 2013-2017 (% of total)
Figure 85:European Country Population Aged 65 and Above, 2012-2016 (% of Total)
Figure 86:Share of Generics in Pharmaceutical Market Sales, By Volume (Ex-Factory Prices)
Figure 87:Western Europe DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 88:Western Europe DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 89:Western Europe DALYs of COPD (2013-2016, %)
Figure 90:Western Europe DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 91:Western Europe DALYs of Diabetes (2013-2016 %)
Figure 92:Breakdown of Total Health Expenditure in Europe (%)
Figure 93:Major Players in Pharmaceutical Packaging Equipment Market in North America
Figure 94:Europe Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 95:Europe Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 96:U.K Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 97:U.K, Per Capita Health Expenditure, 2013-2017 (USD)
Figure 98:U.K, Health Expenditure, Share of GDP, 2013-2017 (In %)
Figure 99:United Kingdom DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 100:United Kingdom DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 101:United Kingdom DALYs of COPD (2013-2016 %)
Figure 102:United Kingdom DALYs of Alzheimer Disease and Other Dementias (2013-2016 %)
Figure 103:United Kingdom DALYs of Diabetes (2013-2016, %)
Figure 104:U.K Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 105:U.K Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 106:Germany Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 107:Upcoming patent expiry on lucrative biopharmaceuticals
Figure 108:Germany, Yearly vale of exported pharmaceuticals, 2012-2016 (In Billion Euro)
Figure 109:Germany, Population ages 65 and above, 2012-2016 (% total)
Figure 110:Germany, Per Capita Health Expenditure, 2013-2017 (USD)
Figure 111:Germany, Health Expenditure, Share of GDP, 2013-2017 (In %)
Figure 112:Germany DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 113:Germany DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 114:Germany DALYs of COPD (2013-2016,%)
Figure 115:Germany DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 116:Germany DALYs of Diabetes (2013-2016, %)
Figure 117:Germany Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 118:Germany Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 119:Europe Pharmaceutical Packaging Equipment Market, Country Share, Historic, 2013-2017(% of Total)
Figure 120:Europe Pharmaceutical Packaging Equipment Market, Country Share, Forecast, 2018-2023 (% of Total)
Figure 121:APAC Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2017 (USD Billion)
Figure 122:APAC Pharmaceutical Packaging Equipment Market Size, By Value, Forecast, 2018-2023(USD Billion)
Figure 123:Population ages 65 and above, APAC Region, By Select Countries, 2016 (% of total)
Figure 124:Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
Figure 125:South East Asia, East Asia, Oceania , DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 126:South East Asia, East Asia, Oceania DALYs of Chronic Kidney Disease(2013-2016, %)
Figure 127:South East Asia, East Asia, Oceania DALYs of COPD (2013-2016, %)
Figure 128:South East Asia, Oceania, DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 129:South East Asia, East Asia, Oceania DALYs of Diabetes (2013-2016, %)
Figure 130:APAC Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 131:APAC Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 132:India Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 133:India, GDP Growth Per Year, 2015-2019 (In %)
Figure 134:India, Total Population, 2012-2022F (In Billion)
Figure 135:India DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 136:India DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 137:India DALYs of COPD (2013-2016, %)
Figure 138:India DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 139:India DALYs of Diabetes (2013-2016 %)
Figure 140:India Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 141:India Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 142:China Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 143:China, Population ages 65 and above, 2012-2016 (% of total)
Figure 144:China Healthcare Expenditure Outlook (%)
Figure 145:China, GDP Growth Per Year, 2015-2019 (In %)
Figure 146:China, Total Population, 2012-2022F (In Billion)
Figure 147:China DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 148:China DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 149:China DALYs of COPD (2013-2016, %)
Figure 150:China DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 151:China DALYs of Diabetes (2013-2016, %)
Figure 152:China Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 153:China Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 154:APAC Pharmaceutical Packaging Equipment Market, Country Share, 2013-2017 (% of Total)
Figure 155:APAC Pharmaceutical Packaging Equipment Market, Country Share, 2018-2023 (% of Total)
Figure 156:ROW Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 157:Latin America and Caribbean, Total Population, 2012-2016
Figure 158:Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2016 (In %)
Figure 159:Middle East and North Africa, Total Population, 2012-2016
Figure 160:Middle East and North Africa, GDP, 2012-2016 (In Trillion USD)
Figure 161:ROW Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 162:ROW Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 163:Brazil Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 164:Cost of medical procedures in Brazil and equivalent procedures in the U.S
Figure 165:Brazil DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 166:Brazil DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 167:Brazil DALYs of COPD (2013-2016, %)
Figure 168:Brazil DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 169:Brazil DALYs of Diabetes (2013-2016, %)
Figure 170:Brazil Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 171:Mexico Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 172:Mexico Pharmaceutical Packaging Equipment Market Size, By Value, 2013-2023 (USD Billion)
Figure 173:Cost of heart procedures in Mexico and equivalent procedures in the U.S
Figure 174:Cost of orthopaedic procedures in Mexico and equivalent procedures in the U.S
Figure 175:Cost of cosmetic procedures in Mexico and equivalent procedures in the U.S
Figure 176:Cost of dental procedures in Mexico and equivalent procedures in the U.S
Figure 177:Mexico Pharmaceutical Packaging Equipment Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 178:Mexico Pharmaceutical Packaging Equipment Market: By Package Type, By Value, 2013-2023 (USD Billion)
Figure 179:Körber AG, Sales, 2012-2017 (USD Million)
Figure 180:Bosch Group, Sales Revenue, 2013-2017 (USD Billion)
Figure 181:Bosch Group, Sales, By Business Sector, 2017 (%)
Figure 182:Bosch Group, Associates, By Region, 2017 (%)
Figure 183:IMA S.p.A, Sales, 2013-2017 (USD Million)
Figure 184:IMA S.p.A, Sales, By Business Segment, 2017 (%)
Figure 185:IMA S.p.A, Sales, By Geography, 2017 (%)
Figure 186:IMA S.p.A, Pharmaceutical Sales, 2013-2017 (USD Million)
Figure 187:IMA S.p.A, Revenue, By Nature, 2017 (In %)
List of Tables
Table A:List of Abbreviations
Table B:Medical Tourism Index, By Region and Top Destinations
Table C:Recent Company Acquisitions in Pharmaceutical Packaging Equipment Market
Table D:Global Pharmaceutical Packaging Equipment Market - Company Share, 2018E (%)
Table E:Pricing Analysis of Pharmaceutical Packaging Equipment